Try our Advanced Search for more refined results
Searching dockets in Llorens Pharmaceutical x
Alert me of new activity
All Case Activity Alerts Include: Answers, Appeals, Complaints, Motions, Orders, Trial Notes
P.I.: Other | New York Southern
Notice to Attorney Regarding Case Opening Statistical Error Correction
***NOTICE TO ATTORNEY REGARDING CIVIL CASE OPENING STATISTICAL ERROR CORRECTION: Notice to attorney Armando Llorens. The following case opening statistical information was erroneously selected/entered: Cause of Action code M 94 Other; Dollar Demand $1,000,000,000; County code Albany;. The following correction(s) have been made to your case entry: the Cause of Action code has been modified to 28:1332; the Dollar Demand has been modified to $1,000,000; the County code has been modified to XX Out of State;. Corrections were updated as per the Complaint. (jgo)
Notice to Attorney Regarding Party Modification
***NOTICE TO ATTORNEY REGARDING PARTY MODIFICATION. Notice to attorney Armando Llorens. The party information for the following party/parties has been modified: Llorens Pharmaceutical Corp.; Richard Caldwell. The information for the party/parties has been modified for the following reason/reasons: party role was entered incorrectly;. (jgo)
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login
Email (NOTE: Free email domains not supported)
First Name
Last Name
Job Title
PLEASE NOTE: A verification email will be sent to your address before you can access your trial.
Password (at least 8 characters required)
Confirm Password
Law360 may contact you in your professional capacity with information about our other products, services and events that we believe may be of interest.You’ll be able to update your communication preferences via the unsubscribe link provided within our communications.We take your privacy seriously. Please see our Privacy Policy.